LINDSEY LANDRENEAU: Open Payments
NPI 1689413700 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,399 in 119 payments from 30 companies in 2025. Trend: 2023 $0 · 2024 $415 · 2025 $2,399
Food & beverage: $2,002Education: $224Travel & lodging: $173
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $541 |
| UCB, Inc. | 18 | $266 |
| JAZZ PHARMACEUTICALS INC. | 7 | $204 |
| Abbott Laboratories | 4 | $181 |
| Axsome Therapeutics, Inc. | 7 | $166 |
| Lundbeck LLC | 5 | $103 |
| Biogen, Inc. | 4 | $72 |
| HARMONY BIOSCIENCES LLC | 1 | $70 |
| Grifols USA, LLC | 3 | $65 |
| TG Therapeutics, Inc. | 3 | $64 |
Products named: QULIPTA, XYWAV, INFINITY, Sunosi, UBRELVY, Leqembi, Briviact, Fintepla.
Industry payments across LA — which companies pay providers there.
